|
ZNF696 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.99584793136864E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.29160024289854E-11 |
| Normal-vs-Stage2 |
4.151200E-04 |
| Normal-vs-Stage3 |
6.43207709316584E-12 |
| Normal-vs-Stage4 |
1.69310000464051E-08 |
| Stage1-vs-Stage2 |
2.070200E-01 |
| Stage1-vs-Stage3 |
3.087800E-02 |
| Stage1-vs-Stage4 |
1.594960E-01 |
| Stage2-vs-Stage3 |
1.536040E-02 |
| Stage2-vs-Stage4 |
5.934300E-02 |
| Stage3-vs-Stage4 |
8.368800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.32059951652286E-10 |
| Normal-vs-AfricanAmerican |
3.578800E-04 |
| Normal-vs-Asian |
5.773700E-04 |
| Caucasian-vs-AfricanAmerican |
8.731800E-01 |
| Caucasian-vs-Asian |
1.437600E-02 |
| AfricanAmerican-vs-Asian |
2.875800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.77889999900083E-08 |
| Normal-vs-Female |
1.81177295388579E-12 |
| Male-vs-Female |
2.423200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.53840323497457E-11 |
| Normal-vs-Age(41-60Yrs) |
6.90020263149904E-11 |
| Normal-vs-Age(61-80Yrs) |
4.63329999922379E-08 |
| Normal-vs-Age(81-100Yrs) |
7.635500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.100200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.700400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.703800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.203800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.417600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.914800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.33330000040566E-07 |
| Classical-VS-Follicular |
1.101050E-01 |
| Classical-VS-Other |
7.433000E-01 |
| Classical-VS-Normal |
9.52837808654294E-12 |
| Tall-VS-Follicular |
5.0648999994074E-08 |
| Tall-VS-Other |
1.293040E-01 |
| Tall-VS-Normal |
1.3988810110277E-14 |
| Follicular-VS-Other |
8.531200E-01 |
| Follicular-VS-Normal |
1.96425999999805E-05 |
| Other-VS-Normal |
4.262000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.95760000432088E-08 |
| Normal-vs-N1 |
6.7544999593494E-09 |
| N0-vs-N1 |
8.745800E-02 |
|
|
